Matches in SemOpenAlex for { <https://semopenalex.org/work/W4294940226> ?p ?o ?g. }
- W4294940226 abstract "To identify the biomarkers in the critical period of development in diabetic retinopathy (DR) in Chinese with type 2 diabetes using targeted and untargeted metabolomics, and to explore the feasibility of their clinical application.This case-control study described the differential metabolites between 83 Chinese type 2 diabetes mellitus (T2DM) samples with disease duration ≥ 10 years and 27 controls matched cases. Targeted metabolomics using high-resolution mass spectrometry with liquid chromatography was performed on plasma samples of subjects. The results were compared to our previous untargeted metabolomics study and ELISA was performed to validate the mutual differential metabolites of targeted and untargeted metabolomics on plasma. Multiple linear regression analyses were performed to adjust for the significance of different metabolites between groups.Mean age of the subjects was 66.3 years and mean T2DM duration was 16.5 years. By cross-validating with results from previous untargeted metabolomic assays, we found that L-Citrulline (Cit), indoleacetic acid (IAA), 1-methylhistidine (1-MH), phosphatidylcholines (PCs), hexanoylcarnitine, chenodeoxycholic acid (CDCA) and eicosapentaenoic acid (EPA) were the most distinctive metabolites biomarkers to distinguish the severity of DR for two different metabolomic approaches in our study. We mainly found that samples in the DR stage showed lower serum level of Cit and higher serum level of IAA compared with samples in the T2DM stage, while during the progression of diabetic retinopathy, the serum levels of CDCA and EPA in PDR stage were significantly lower than NPDR stage. Among them, 4 differential key metabolites including Cit, IAA, CDCA and EPA were confirmed with ELISA.This is the first study to compare the results of targeted and untargeted metabolomics via liquid chromatography-mass spectrometry to find the serum biomarkers which could reflect the metabolic variations among different stages of DR in Chinese. The progression of DR in Chinese at different critical stages was related to the serum levels of specific differential metabolites, of which there is a significant correlation between DR progression and increased IAA and decreased Cit, hexanoylcarnitine, CDCA, and EPA. However, larger studies are needed to confirm our results. Based on this study, it could be inferred that the accuracy of targeted metabolomics for metabolite expression in serum is to some extent higher than that of untargeted metabolomics." @default.
- W4294940226 created "2022-09-08" @default.
- W4294940226 creator A5003336327 @default.
- W4294940226 creator A5005135027 @default.
- W4294940226 creator A5006938082 @default.
- W4294940226 creator A5018457347 @default.
- W4294940226 creator A5019923093 @default.
- W4294940226 creator A5024249090 @default.
- W4294940226 creator A5034579434 @default.
- W4294940226 creator A5043839113 @default.
- W4294940226 creator A5060279319 @default.
- W4294940226 creator A5060674585 @default.
- W4294940226 creator A5064108204 @default.
- W4294940226 creator A5069336881 @default.
- W4294940226 creator A5080926287 @default.
- W4294940226 date "2022-09-08" @default.
- W4294940226 modified "2023-10-03" @default.
- W4294940226 title "Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes" @default.
- W4294940226 cites W1879293728 @default.
- W4294940226 cites W1966206262 @default.
- W4294940226 cites W1976928728 @default.
- W4294940226 cites W2011633921 @default.
- W4294940226 cites W2021322411 @default.
- W4294940226 cites W2028875268 @default.
- W4294940226 cites W2031329209 @default.
- W4294940226 cites W2032147202 @default.
- W4294940226 cites W2076232924 @default.
- W4294940226 cites W2076304999 @default.
- W4294940226 cites W2085485348 @default.
- W4294940226 cites W2107445190 @default.
- W4294940226 cites W2129362189 @default.
- W4294940226 cites W2130266732 @default.
- W4294940226 cites W2145239202 @default.
- W4294940226 cites W2158958532 @default.
- W4294940226 cites W2168261002 @default.
- W4294940226 cites W2169845921 @default.
- W4294940226 cites W2175704762 @default.
- W4294940226 cites W2324826022 @default.
- W4294940226 cites W2395083517 @default.
- W4294940226 cites W2509396687 @default.
- W4294940226 cites W2538116180 @default.
- W4294940226 cites W2587078170 @default.
- W4294940226 cites W2613414011 @default.
- W4294940226 cites W2734873447 @default.
- W4294940226 cites W2793455362 @default.
- W4294940226 cites W2806010784 @default.
- W4294940226 cites W2849298850 @default.
- W4294940226 cites W2886401819 @default.
- W4294940226 cites W2912181843 @default.
- W4294940226 cites W2937321763 @default.
- W4294940226 cites W2945245630 @default.
- W4294940226 cites W2951535213 @default.
- W4294940226 cites W2962927362 @default.
- W4294940226 cites W2980938396 @default.
- W4294940226 cites W2984600408 @default.
- W4294940226 cites W2996136049 @default.
- W4294940226 cites W3000559775 @default.
- W4294940226 cites W3036693821 @default.
- W4294940226 cites W3082923392 @default.
- W4294940226 cites W3083228456 @default.
- W4294940226 cites W3092532329 @default.
- W4294940226 cites W3093982449 @default.
- W4294940226 cites W3096174763 @default.
- W4294940226 cites W3116894212 @default.
- W4294940226 cites W3133373643 @default.
- W4294940226 cites W3133420360 @default.
- W4294940226 cites W3134645880 @default.
- W4294940226 cites W3182271377 @default.
- W4294940226 cites W4220787573 @default.
- W4294940226 cites W4221062384 @default.
- W4294940226 cites W4285745424 @default.
- W4294940226 doi "https://doi.org/10.3389/fendo.2022.986303" @default.
- W4294940226 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36157454" @default.
- W4294940226 hasPublicationYear "2022" @default.
- W4294940226 type Work @default.
- W4294940226 citedByCount "2" @default.
- W4294940226 countsByYear W42949402262023 @default.
- W4294940226 crossrefType "journal-article" @default.
- W4294940226 hasAuthorship W4294940226A5003336327 @default.
- W4294940226 hasAuthorship W4294940226A5005135027 @default.
- W4294940226 hasAuthorship W4294940226A5006938082 @default.
- W4294940226 hasAuthorship W4294940226A5018457347 @default.
- W4294940226 hasAuthorship W4294940226A5019923093 @default.
- W4294940226 hasAuthorship W4294940226A5024249090 @default.
- W4294940226 hasAuthorship W4294940226A5034579434 @default.
- W4294940226 hasAuthorship W4294940226A5043839113 @default.
- W4294940226 hasAuthorship W4294940226A5060279319 @default.
- W4294940226 hasAuthorship W4294940226A5060674585 @default.
- W4294940226 hasAuthorship W4294940226A5064108204 @default.
- W4294940226 hasAuthorship W4294940226A5069336881 @default.
- W4294940226 hasAuthorship W4294940226A5080926287 @default.
- W4294940226 hasBestOaLocation W42949402261 @default.
- W4294940226 hasConcept C126322002 @default.
- W4294940226 hasConcept C134018914 @default.
- W4294940226 hasConcept C185592680 @default.
- W4294940226 hasConcept C21565614 @default.
- W4294940226 hasConcept C2777180221 @default.
- W4294940226 hasConcept C2779829184 @default.
- W4294940226 hasConcept C43617362 @default.
- W4294940226 hasConcept C555293320 @default.